Rankings · Growth
Free cash flow growing fastest
Graded A or B, with at least $250M of free cash flow now and $100M three years ago, ranked by its yearly growth over those three years. Banks, insurers and brokers are left out: their cash flow moves with customers’ money.
70 companies meet this test
Figures as of October 1, 2026
| # | Company | Grade | Free cash flow growth | Revenue growth | Free cash flow yield | Market value |
|---|---|---|---|---|---|---|
| 1 | SNNSmith & Nephew plc | A | +98% a year | +6% a year | 7.2% | $11.8B |
| 2 | GMEDGLOBUS MEDICAL, INC. | A+ | +84% a year | +42% a year | 7.4% | $10.2B |
| 3 | LLYELI LILLY AND COMPANY | A+ | +70% a year | +39% a year | 1.6% | $1.12T |
| 4 | RVTYREVVITY, INC | A | +54% a year | +1% a year | 3.3% | $17.1B |
| 5 | EHCEncompass Health Corporation | B+ | +49% a year | +11% a year | 3.4% | $12.2B |
| 6 | EXELExelixis Inc | A+ | +49% a year | +12% a year | 8.1% | $14.5B |
| 7 | THCTENET HEALTHCARE CORP | A+ | +47% a year | +3% a year | 14.6% | $20.8B |
| 8 | NBIXNEUROCRINE BIOSCIENCES INC | A+ | +46% a year | +26% a year | 6.2% | $14.1B |
| 9 | COOThe Cooper Companies, Inc. | A | +45% a year | +6% a year | 6.3% | $10.8B |
| 10 | DXCMDEXCOM, INC. | A+ | +44% a year | +16% a year | 4.3% | $32.7B |
| 11 | ALCAlcon Inc. | B | +44% a year | +3% a year | 5.4% | $31.9B |
| 12 | RMDResMed Inc. | B+ | +42% a year | +10% a year | 5.1% | $32.2B |
| 13 | HALOHALOZYME THERAPEUTICS, INC. | A+ | +40% a year | +29% a year | 6.4% | $12.7B |
| 14 | ISRGIntuitive Surgical, Inc. | A+ | +40% a year | +18% a year | 2.2% | $145.6B |
| 15 | HRMYHARMONY BIOSCIENCES HOLDINGS, INC. | A+ | +34% a year | +24% a year | 15.2% | $2.3B |
| 16 | BSXBOSTON SCIENTIFIC CORPORATION | B+ | +34% a year | +16% a year | 5.7% | $63.6B |
| 17 | ICLRICON plc | A | +32% a year | +2% a year | 6.8% | $13B |
| 18 | HQYHEALTHEQUITY, INC. | A+ | +32% a year | +13% a year | 6.8% | $7.2B |
| 19 | IDXXIDEXX LABORATORIES INC /DE | A+ | +28% a year | +9% a year | 3.0% | $42B |
| 20 | EWEdwards Lifesciences Corporation | A+ | +27% a year | +15% a year | 2.8% | $50.8B |
| 21 | SYKSTRYKER CORP | A+ | +25% a year | +10% a year | 4.4% | $107B |
| 22 | CAHCardinal Health, Inc. | A | +24% a year | +7% a year | 8.7% | $52.1B |
| 23 | MEDPMedpace Holdings, Inc. | A+ | +24% a year | +18% a year | 4.1% | $17.4B |
| 24 | STESTERIS plc | B+ | +23% a year | +9% a year | 4.5% | $20.5B |
| 25 | ATRAptarGroup, Inc | A | +23% a year | +5% a year | 4.0% | $7.8B |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.